Breakthroughs in medical science and clinical trials.
Medical ResearchThe FDA's accelerated approval of next-generation incretin therapies and Phase 3 MCED data marks a structural pivot from...
Read More →
Medical ResearchThe successful Phase 3 completion of in vivo base-editing therapy for Lp(a) reduction marks a permanent shift from chron...
Read More →
Medical ResearchThe CMS mandate for blood-based p-tau217 biomarker assays is fundamentally shifting Alzheimer's diagnostics from costly ...
Read More →Medical Research[Five October 2026 medical breakthroughs—retatrutide approval, Alzheimer's blood test coverage, CRISPR durability data...
Read More →
Medical ResearchThe medical research sector faces a critical reckoning as algorithmic hype collides with clinical realities and severe f...
Read More →Medical ResearchMedical research achieved unprecedented breakthroughs in 2025 with oral GLP-1 therapies, CRISPR gene editing, and Alzhei...
Read More →
Medical ResearchThe simultaneous maturation of AI-discovered molecules, in vivo CRISPR editing, and viable xenotransplantation has perma...
Read More →
Medical ResearchThis week's convergence of FDA AI clearances, NIH funding shifts, microplastic pathology data, mRNA oncology success, an...
Read More →
Medical ResearchThe convergence of AI-driven target identification and in vivo gene editing marks the definitive end of empirical drug d...
Read More →
Medical ResearchThe FDA’s approval of an in vivo CRISPR therapy and Medicare’s new outcomes-based rebate framework are fundamentally...
Read More →